{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:10:21Z","timestamp":1760825421957,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jocn.2021.09.026","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:40:52Z","timestamp":1632271252000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Survival prediction and conditional survival of primary central nervous system lymphoma: A population-based study"],"prefix":"10.1016","volume":"93","author":[{"given":"Boxi","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jocn.2021.09.026_b0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcp\/110.5.607","article-title":"Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'\u00e9tude des Leuc\u00e9nies et Autres Maladies du Sang (GOELAMS)","volume":"110","author":"Camilleri-Bro\u00ebt","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.jocn.2021.09.026_b0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23551","article-title":"The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma","volume":"88","author":"O'Neill","year":"2013","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jocn.2021.09.026_b0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bjh.14073","article-title":"Trends in primary central nervous system lymphoma incidence and survival in the U.S","volume":"174","author":"Shiels","year":"2016","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jocn.2021.09.026_b0020","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/bjc.2011.357","article-title":"Age, gender, and racial differences in incidence and survival in primary CNS lymphoma","volume":"105","author":"Villano","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.jocn.2021.09.026_b0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3109\/10428194.2014.961014","article-title":"The role of radiation therapy in the management of primary central nervous system lymphoma","volume":"56","author":"Milgrom","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.jocn.2021.09.026_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.62.10.1595","article-title":"Delayed neurotoxicity in primary central nervous system lymphoma","volume":"62","author":"Omuro","year":"2005","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2021.09.026_b0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.hpb.2016.04.001","article-title":"Conditional probability of long-term survival after resection of hilar cholangiocarcinoma","volume":"18","author":"Buettner","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jocn.2021.09.026_b0040","first-page":"5v1-49","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14 Suppl","author":"Dolecek","year":"2012","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2021.09.026_b0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jocn.2021.09.026_b0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/neuonc\/nox187","article-title":"The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades","volume":"20","author":"Mendez","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2021.09.026_b0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-010-0269-7","article-title":"Survival among patients with primary central nervous system lymphoma, 1973\u20132004","volume":"101","author":"Norden","year":"2011","journal-title":"J Neurooncol"},{"issue":"9","key":"10.1016\/j.jocn.2021.09.026_b0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jocn.2021.09.026_b0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1215\/15228517-2008-103","article-title":"Racial differences in primary central nervous system lymphoma incidence and survival rates","volume":"11","author":"Pulido","year":"2009","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2021.09.026_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COC.0000000000000639","article-title":"Black patients experience highest rates of cancer-associated venous thromboembolism","volume":"43","author":"Addo-Tabiri","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2021.09.026_b0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/NEN.0000000000000076","article-title":"CNS lymphoma: a practical diagnostic approach","volume":"73","author":"Giannini","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2021.09.026_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2021.09.026_b0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.40.1.80","article-title":"Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy","volume":"40","author":"DeAngelis","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.09.026_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2020.03.150","article-title":"Risk factors for early mortality in patients with primary central nervous system lymphoma: a large-cohort retrospective study","author":"Zhou","year":"2020","journal-title":"World Neurosurg"},{"issue":"12","key":"10.1016\/j.jocn.2021.09.026_b0095","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/nos159","article-title":"Surgery for primary CNS lymphoma? Challenging a paradigm","volume":"14","author":"Weller","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2021.09.026_b0100","article-title":"Real-world impact of surgical excision on overall survival in primary central nervous system lymphoma","volume":"10131","author":"Deng","year":"2020","journal-title":"Front Oncol"},{"issue":"9700","key":"10.1016\/j.jocn.2021.09.026_b0105","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0140-6736(09)61416-1","article-title":"High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial","volume":"374","author":"Ferreri","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jocn.2021.09.026_b0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2021.09.026_b0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4103\/ajns.AJNS_208_20","article-title":"Outcome and Prognostic Factors of Primary Central Nervous System Lymphoma in Southern Thailand","volume":"15","author":"Sopittapan","year":"2020","journal-title":"Asian J Neurosurg"},{"issue":"7","key":"10.1016\/j.jocn.2021.09.026_b0120","article-title":"A regional multicenter retrospective analysis of patients with primary central nervous system lymphoma diagnosed from 2000\u20132012: treatment patterns and clinical outcomes","volume":"9","author":"Burton","year":"2017","journal-title":"Cureus"},{"issue":"16","key":"10.1016\/j.jocn.2021.09.026_b0125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010385","article-title":"Marital status and survival in patients with renal cell carcinoma","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.jocn.2021.09.026_b0130","doi-asserted-by":"crossref","DOI":"10.5489\/cuaj.5413","article-title":"The impact of marriage on the overall survival of prostate cancer patients: A Surveillance, Epidemiology, and End Results (SEER) analysis","volume":"13","author":"Liu","year":"2019","journal-title":"Can Urol Assoc J"},{"issue":"10","key":"10.1016\/j.jocn.2021.09.026_b0135","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/cncr.26553","article-title":"Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent","volume":"118","author":"Mayo","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jocn.2021.09.026_b0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2013.09.050","article-title":"Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jocn.2021.09.026_b0145","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jamcollsurg.2009.12.041","article-title":"Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients","volume":"210","author":"Nathan","year":"2010","journal-title":"J Am Coll Surg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821004823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821004823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:28:54Z","timestamp":1760822934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821004823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"alternative-id":["S0967586821004823"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.09.026","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival prediction and conditional survival of primary central nervous system lymphoma: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}